Health Canada Update
On February 24, 2017, Health Canada issued the Terms of Reference for the Scientific Advisory Panel on Opioid Use and Contraindications (SAP-OUC). According to Health Canada’s website, the SAP-OUC will “examine whether contraindications currently included in Canadian labelling of opioids are sufficient or should be modified, and whether additional contraindications should be added. While the Panel provides Health Canada with advice and recommendations, the decision-making responsibility remains with Health Canada.” Please select the URL below to access additional information related to the SAP-OUC’s:
- Reporting Structure
- Roles and Responsibilities
- Management and Administration
To receive updates similar to this one please be sure to sign up for Market Access Signals, our free e-mail newsletter service.